Compare SNES & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNES | MRM |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Other Consumer Services |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6M | 7.6M |
| IPO Year | 2016 | 2020 |
| Metric | SNES | MRM |
|---|---|---|
| Price | $0.82 | $0.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 49.5K | 8.7K |
| Earning Date | 05-07-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $600,000.00 | N/A |
| Revenue This Year | $29.00 | N/A |
| Revenue Next Year | $95.04 | N/A |
| P/E Ratio | ★ N/A | $32.01 |
| Revenue Growth | ★ 132.56 | N/A |
| 52 Week Low | $0.79 | $0.73 |
| 52 Week High | $4.86 | $4.45 |
| Indicator | SNES | MRM |
|---|---|---|
| Relative Strength Index (RSI) | 24.02 | 28.26 |
| Support Level | N/A | N/A |
| Resistance Level | $1.76 | $1.02 |
| Average True Range (ATR) | 0.05 | 0.05 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 19.86 | 19.01 |
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company has developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Its current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.